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Chromosomal rearrangements in acute myeloid leukaemia 
(AML) frequently give rise to aberrant fusion proteins, 
responsible for the disease onset (50% of all reported cases). 
Five per cent of such cases harbour rare rearrangements, 
mostly translocations, resulting either in new rare fusion 
products or in the deregulation/truncation of specific genes. In 
this specific case, a new rearrangement between chromosomes 
7 and 8 gives rise to a new abnormal fusion product between 
the FGFR1 and TIF1 genes. 
Fluorescence  in situ hybridization (FISH) can be used to 
evidence the presence of such a rearrangement, by selecting
genomic clones mapping in the chromosomal region that 
contains the breakpoint. The presence of the rearrangement 
can be detected in both interphase and metaphase nuclei. In 
the shown image, the clone 350N11, spanning the FGFR1 
locus, has been labelled in red and used to hybridize interphase 
and metaphase nuclei (stained with DAPI, blue) on bone 
marrow cells derived from the patient. The presence of three 
signals indicates the clone is recognizing the normal 
chromosome 8, as well as the two derivative chromosomes 7 
and 8, proving the presence of the breakpoint within this gene. 
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